Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: Can the change in prostate-specific antigen reliably guide prostate biopsy decisions?

Urologia Internationalis

Volumn 87, Issue 4, 2011, Pages 416-419

  Torky, Mohammed ^a   Mosharafa, Ashraf ^a,b   Emran, Ashraf ^a   Kamal, Ayman ^a   Abdelhamid, Mohammed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Biopsy, needle; Prostate specific antigen; Prostatic neoplasms; Prostatitis

Indexed keywords

LEVOFLOXACIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84255166980     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000331706     Document Type: Article

References (23)

1. Carver B, Bozeman CB, Williams BJ, Venable DD: The prevalence of men with national institutes of health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003; 169: 589-591. (Pubitemid 36132991)
2. Stancik I, Lüftenegger W, Klimpfinger M, Müller MM, Hoeltl W: Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004; 46: 760-764. (Pubitemid 39488408)
3. Potts JM: Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164: 1550-1553.
4. Kaygisiz O, Ugurlu O, Kosan M, Inal G, Oztürk B, Cetinkaya M: Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ ml. Prostate Cancer Prostatic Dis 2006; 9: 235-238. (Pubitemid 44317256)
5. Karazanashvili G, Managadze L: Prostatespecific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol 2001; 239: 538-543. (Pubitemid 32678968)
6. Kobayashi M, Nukui A, Morita T: Serum PSA and percent free PSA value changes after antibiotic treatment: A diagnostic method in prostate cancer suspects with asymptomatic prostatitis. Urol Int 2008; 80: 186-192. (Pubitemid 351440515)
7. Stopiglia RM, Ferreira U, Silva MM Jr, Matheus WE, Denardi F, Reis LO: Prostate specific antigen decrease and prostate cancer diagnosis: Antibiotic versus placebo prospective randomized clinical trial. J Urol 2010; 183: 940-945.
8. Shtricker A, Shefi S, Ringel A, Gillon G: PSA levels of 4.0-10 ng/ml and negative digital rectal examination: Antibiotic therapy versus immediate prostate biopsy. Int Braz J Urol 2009; 35: 551-555.
9. Baltaci S, Süer E, Haliloglu AH, Gokce MI, Elhan AH, Bedük Y: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. J Urol 2009; 181: 128-132.
10. Nixon RG, Wener MH, Smith KM, et al: Biological variation of prostate specific antigen levels in serum: An evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol 1997; 157: 2183-2190. (Pubitemid 27208668)
11. Roehrbornab CG, Pickensab GJ, Carmody T: Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population. Urology 1996; 47: 59-66.
12. Shariat SF, Scardino PT, Lilja H: Screening for prostate cancer: An update. Can J Urol 2008; 15: 4363-4374.
13. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P: Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182: 2232-2241.
14. Terrone C, Poggio M, Bollito E, Cracco CM, Scarpa RM: Asymptomatic prostatitis: A frequent cause of raising PSA (in Italian). Recenti Prog Med 2005; 96: 365-369. (Pubitemid 41078769)
15. Serretta V, Catanese A, Daricello G, Liotta R, Allegro R, Martorana A, Aragona F, Melloni D: PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Prostate Cancer Prostatic Dis 2008; 11: 148-152. (Pubitemid 351676603)
16. Lorente JA, Arango O, Bielsa O, Cortadellas R, Gelabert-Mas A: Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers 2002; 17: 84-89. (Pubitemid 34873792)
17. Guercio S, Terrone C, Tarabuzzi R, Poggio M, Cracco C, Bollito E, Scarpa RM: PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl 2004; 76: 154-158. (Pubitemid 40127779)
18. Schaeffer AJ, Wu S-C, Tennenberg AM, Kahn JB: Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. J Urol 2005; 174: 161-164. (Pubitemid 40825702)
19. Habermacher GM, Chason JT, Schaeffer AJ: Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 2006; 57: 195-206. (Pubitemid 43261987)
20. Shimomura T, Kiyota H, Takahashi H, Madarame J, Kimura T, Onodera S: Prostate histopathology of NIH category IV prostatitis detected by sextant prostate needle biopsy from the patients with high prostatic specific antigen. Kansenshogaku Zasshi 2003; 77: 611-617.
21. Nam RK, Saskin R, Lee Y, et al: Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963-968.
22. Feliciano J, Teper E, Ferrandino M, et al: The incidence of fluoroquinolone resistant infections after prostate biopsy - are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952-955.
23. Shigehara K, Miyagi T, Nakashima T, et al: Acute bacterial prostatitis after transrectal prostate needle biopsy: Clinical analysis. J Infect Chemother 2008; 14: 40-43. (Pubitemid 351311436)